REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

13/04/2017 09:00

RNS Number : 4403C
Hikma Pharmaceuticals Plc
13 April 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Michael Raya
2
Reason for the notification
a)
Position/status
CEO of West-Ward Pharmaceuticals
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Further Shares disposed from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). An additional 2,370 shares were sold to cover tax and associated costs resulting in 9,383 shares being retained.
c)
Price(s) and volume(s)
Price
Volume(s)
19.42
2,370
0.00
9,383
d)
Aggregated information
19.42
46,025
e)
Date of the transaction
12 April 2017
f)
Place of the transaction
London Stock Exchange (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHGRGDSLUBBGRX